HIGHLIGHTS
- who: Peter Keating from the Department of History, Université du Québec à Montréal, Canada Department of Social Studies of Medicine, McGill University, Canada have published the article: Therapy's shadow: a short history of the study of resistance to cancer chemotherapy, in the Journal: (JOURNAL)
- what: In the case of chronic myelogenous leukemia, the authors have two distinct clusters that appear to correspond to different stages of development: first, to the initial exploration of the BCR-ABL translocation and the development of imatinib, followed by a second set of studies focusing on point mutations . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.